
Optimal lipids, statins, and dementia
Optimal lipids, statins, and dementia: Reply

A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids
Contribution of regulatory and structural variations in APOE to predicting dyslipidemia
Metabolic effects of intravenous LCT or MCT/LCT lipid emulsions in preterm infants
Saturated fat-induced changes in Sf 60–400 particle composition reduces uptake of LDL by HepG2 cells
Swelling of phospholipids by monovalent salt
Transfer of very low density lipoprotein-associated phospholipids to activated human platelets
